CAC2 Childhood Cancer Community News Digest (April 27-May 3)

Assorted News from the Last Week:

A pioneering trial from Cancer Grand Challenges team NexTGen will test CAR-T cell therapies designed from CAC2 Supporting Organization Eureka Therapeutic’s ARTEMIS platform.  The trial is specifically designed for children and young people with sarcomas. 

Congratulations to CAC2 Supporting Organization Servier, for successfully completing the tender offer to acquire all of the issued and outstanding shares of common stock of CAC2 Supporting Organization Member Day One Biopharmaceuticals, Inc.

CAC2 recently hosted Understanding Childhood Cancer Risk and Early Indicators,” to explore important and evolving question in pediatric oncology: how can we better understand risk, improve early detection, and ultimately move toward prevention?

More news on preventable cause of childhood cancer this week:

Reprogramming lipid metabolism in pediatric cancers.

Repurposed drugs may improve treatment for infant leukemia.

Blocking energy metabolism may help treat an aggressive pediatric brain tumor.

Upcoming Webinars, Online Opportunities, and Meetings:

Following the cancellation of the 2025 Childhood Cancer Data Initiative (CCDI) Symposium originally scheduled for last fall, NCI will inaugurate the CCDI Virtual Symposium Series in the coming weeks. Sessions will occur across multiple days in March and April.  Click Here to Learn More and Register.

National Brain Tumor Society and volunteer advocates from across the country will come together in Washington, D.C., for Head to the Hill on May 3-5, 2026. Register today.

CAC2 Webinar–“Advancing Discovery | The Critical Role of Post-Mortem Tissue Donation in Pediatric Oncology” on May 12 at noon ET.  Click here for information and to register.

On May 19, the Ohio Department of Health will host the 5th Annual Childhood Cancer Summit (virtual).  Click here for information and to register.

Webinar sponsored by TPN.health “Invisible but Impacted: The Critical Role of Supporting Siblings in Peds/AYA Oncology Care” Noon ET on May 27.  Registration link.

Started in 2017, the annual MIB Agents FACTOR conference brings together the leading researchers, clinicians, and surgeons, along with patient families and OsteoWarriors (survivors, patients, and siblings of OsteoWarriors and OsteoAngels) to Make It Better for those battling this disease.  This year the meeting will be in Columbus, Ohio June 25-27.  Click here for information and to register.

 👉 Registration Now Open for the CAC2 Summit in Miami on July 22-24! https://invite.bublup.com/QvcRaOOFd78s

Recent Recordings:

Ying Meng, MD, PhD, shares insights from her clinical trials using focused ultrasound for targeted drug delivery for treating pediatric gliomas and other diseases.

 


SUBSCRIBE

Sign up to receive a copy of CAC2’s free childhood cancer news digest in your inbox each week.

This field is for validation purposes and should be left unchanged.
Name(Required)
Email(Required)

 

Picture of Vickie Buenger

Vickie Buenger

Leave a Reply

Sign up for our Newsletter

We protect your privacy and won’t share your information.